Ally Bridge Group (Ny) LLC Repligen Corp Transaction History

Ally Bridge Group (Ny) LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$162.42 - $220.56 $738,036 - $1 Million	-4,544 Reduced 27.17%	12,180 $2.06 Million
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $2.68 Million - $4.28 Million	16,724 New	16,724 $3.13 Million
Q1 2022 May 16, 2022	SELL	$161.19 - $257.96 $11.3 Million - $18.1 Million	-70,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $2.43 Million - $4.05 Million	-12,500 Reduced 15.15%	70,000 $20.2 Million
Q4 2020 Feb 16, 2021	BUY	$148.08 - $206.57 $12.2 Million - $17 Million	82,500 New	82,500 $15.8 Million

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.98B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.